Insights | Life sciences and pharmaceuticals | United States | Global law firm | Norton Rose Fulbright Skip to main content
Norton Rose Fulbright logo
  • United States
  • About
    • Our firm
      • US Leadership
      • Global coverage
    • People first
      • Equal employment opportunity policy
      • Partnerships and recognitions
      • Resources and support
    • Responsible business
      • Pro bono
      • Community leadership
      • Responsible use of AI
    • We earn 2025 Great Place To Work Certification
      Recipient of the
      2025 Great Place To Work
      Certification

      Learn more
  • People
  • Services
    • Services A-Z
    • Key industries
      • Consumer markets
      • Energy, infrastructure and resources
      • Financial institutions
      • Life sciences and healthcare
      • Technology
      • Transport
    • Practices
      • Antitrust and competition
      • Climate change and sustainability
      • Cybersecurity and data privacy
      • Energy
      • Financial services and regulation
      • Intellectual property
      • Private equity and venture capital
      • Real estate
      • Restructuring
      • Tax
      • Banking and finance
      • Corporate, M&A and securities
      • Employment and labor
      • Environmental, social and governance (ESG)
      • Insurance
      • Litigation and disputes
      • Projects
      • Regulation and investigations
      • Risk advisory
      • White-collar crime
    • LX Studio - A Norton Rose Fulbright subsidiary
      LX Studio
      Accelerating legal innovation

      Visit now
  • Insights
    • Publications
    • Podcasts
    • Blogs
    • Webinars and events
    • Videos
    • LX Studio
    • 2025 Annual Litigation Trends Summit
      2025 Annual Litigation
      Trends Survey

      Learn more
  • News
    • Press releases
    • In the media
    • Market recognitions
    • Media information
    • Recipient of the 2025 Great Place To Work Certification
      Recipient of the
      2025 Great Place To Work
      Certification

      Learn more
  • Locations
    • Austin
    • Chicago
    • Dallas
    • Denver
    • Houston
    • Los Angeles
    • Minneapolis
    • New York
    • San Antonio
    • San Francisco
    • St. Louis
    • Washington, DC
    • Global coverage
  • Careers
    • Search current vacancies
      • Learn more
    • Change
    Norton Rose Fulbright logo

    1. Services
    2. Life sciences and pharmaceuticals

    Life sciences and pharmaceuticals

    Life sciences and pharmaceuticals
    Overview Insights People
    Subscribe to our insights
    • Life sciences and pharmaceuticals
    • Overview
    • Insights
    • People
    • Subscribe to our insights
  • Publication

    Mitigating tariff risks for healthcare in US and Canada

    The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.

    April 21, 2025

    Healthcare
    biotech test tubes

    Publication

    Strategic asset search and evaluation in biopharma

    Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.

    April 16, 2025

    Life sciences and pharmaceuticals
    Generic-buidling-birds-freedom-offices-AdobeStock_405641980

    Publication

    New EU Product Recall Requirements under the General Product Safety Regulation: What do companies need to know?

    Managing a product recall is a challenging scenario for any company as product recalls often need to be conducted urgent...

    April 09, 2025

    Life sciences and pharmaceuticals
    Supreme Court expands RICO liability to economic loss arising out of personal injury

    Publication

    SCOTUS expands RICO liability

    The Supreme Court issued a significant decision in Medical Marijuana v. Horn, impacting civil claims under the Racketeer...

    April 04, 2025

    Litigation and disputes
    Digital Repositories

    Publication

    Digital Health 2025

    Norton Rose Fulbright lawyers Roger Kuan, Jason Novak, Apurv Gaurav, Bernard O'Shea, Rohan Sridhar, Véronique Barry, Van...

    March 28, 2025

    Life sciences and healthcare
    Mitigating Tariff Risks For Healthcare In US And Canada

    Publication

    Mitigating tariff risks for healthcare in US and Canada

    The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.

    April 21, 2025

    Healthcare
    biotech test tubes

    Publication

    Strategic asset search and evaluation in biopharma

    Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.

    April 16, 2025

    Life sciences and pharmaceuticals
    Generic-buidling-birds-freedom-offices-AdobeStock_405641980

    Publication

    New EU Product Recall Requirements under the General Product Safety Regulation: What do companies need to know?

    Managing a product recall is a challenging scenario for any company as product recalls often need to be conducted urgent...

    April 09, 2025

    Life sciences and pharmaceuticals
    Supreme Court expands RICO liability to economic loss arising out of personal injury

    Publication

    SCOTUS expands RICO liability

    The Supreme Court issued a significant decision in Medical Marijuana v. Horn, impacting civil claims under the Racketeer...

    April 04, 2025

    Litigation and disputes
    Digital Repositories

    Publication

    Digital Health 2025

    Norton Rose Fulbright lawyers Roger Kuan, Jason Novak, Apurv Gaurav, Bernard O'Shea, Rohan Sridhar, Véronique Barry, Van...

    March 28, 2025

    Life sciences and healthcare
    More

    Events and webinars

    Competitive edge Quick take FTC’s proposed ban on non-competes

    On demand

    Competitive edge: HSR mini-series

    Watch now
    Consumer markets webinar series: Hot topics in pet products

    On demand

    Consumer markets webinar series: Hot topics in pet products

    Watch now
    Consumer markets webinar series: Manufacturing supply agreements and resulting contract disputes

    On demand

    Consumer markets webinar series: Manufacturing supply agreements and resulting contract disputes

    Watch now
    Subscribe to insights

    Subscribe to our insights

    Stay up to date with the latest publications, podcasts, webinars and events
    Subscribe

    © Norton Rose Fulbright US LLP 2025

    Explore our site

    • About
    • Careers
    • People first
    • People search
    • Services
    • Insights
    • News

    Key industries

    • Consumer markets
    • Energy, infrastructure and resources
    • Financial institutions
    • Life sciences and healthcare
    • Technology
    • Transport

    Locations

    • Global coverage

    Norton Rose Fulbright © 2025. All Rights Reserved.

    Norton Rose Fulbright US LLP is a limited liability partnership registered under the laws of Texas. Attorney Advertising.

    Norton Rose Fulbright US LLP, Norton Rose Fulbright LLP, Norton Rose Fulbright Australia, Norton Rose Fulbright Canada LLP and Norton Rose Fulbright South Africa Inc are separate legal entities and all of them are members of Norton Rose Fulbright Verein, a Swiss verein. Norton Rose Fulbright Verein helps coordinate the activities of the members but does not itself provide legal services to clients.

    • Amsterdam
    • ●
    • Athens
    • ●
    • Austin
    • ●
    • Bangkok
    • ●
    • Beijing
    • ●
    • Brisbane
    • ●
    • Brussels
    • ●
    • Bujumbura**
    • ●
    • Calgary
    • ●
    • Canberra
    • ●
    • Cape Town
    • ●
    • Casablanca
    • ●
    • Chicago
    • ●
    • Dallas
    • ●
    • Denver
    • ●
    • Dubai
    • ●
    • Durban
    • ●
    • Frankfurt
    • ●
    • Hamburg
    • ●
    • Harare**
    • ●
    • Hong Kong
    • ●
    • Houston
    • ●
    • Istanbul
    • ●
    • Jakarta*
    • ●
    • Johannesburg
    • ●
    • Kampala**
    • ●
    • London
    • ●
    • Los Angeles
    • ●
    • Luxembourg
    • ●
    • Melbourne
    • ●
    • Mexico City
    • ●
    • Milan
    • ●
    • Minneapolis
    • ●
    • Montréal
    • ●
    • Munich
    • ●
    • New York
    • ●
    • Nairobi**
    • ●
    • Ottawa
    • ●
    • Paris
    • ●
    • Perth
    • ●
    • Piraeus
    • ●
    • Québec
    • ●
    • Riyadh*
    • ●
    • San Antonio
    • ●
    • San Francisco
    • ●
    • São Paulo
    • ●
    • Shanghai
    • ●
    • Singapore
    • ●
    • St. Louis
    • ●
    • Sydney
    • ●
    • Tokyo
    • ●
    • Toronto
    • ●
    • Vancouver
    • ●
    • Warsaw
    • ●
    • Washington DC *associate office **alliance
    • Legal notices and disclaimers
    • Impressum
    • Standard terms
    • Blog network terms and conditions
    • Cookies policy
    • Privacy notice
    • Website access conditions
    • Fraud alerts
    • Modern Slavery Statements
    • Health plan machine readable files
    • Anti-Facilitation of Tax Evasion Statement
    • Suppliers
    • History
    • Remote access
    • Sitemap
    • Do Not Sell or Share My Personal Information
    • Limit the Use of My Sensitive Personal Information
    Offices and locations

    Norton Rose Fulbright © 2025. All Rights Reserved.

    Norton Rose Fulbright US LLP is a limited liability partnership registered under the laws of Texas. Attorney Advertising.

    Norton Rose Fulbright US LLP, Norton Rose Fulbright LLP, Norton Rose Fulbright Australia, Norton Rose Fulbright Canada LLP and Norton Rose Fulbright South Africa Inc are separate legal entities and all of them are members of Norton Rose Fulbright Verein, a Swiss verein. Norton Rose Fulbright Verein helps coordinate the activities of the members but does not itself provide legal services to clients.

    • Amsterdam
    • ●
    • Athens
    • ●
    • Austin
    • ●
    • Bangkok
    • ●
    • Beijing
    • ●
    • Brisbane
    • ●
    • Brussels
    • ●
    • Bujumbura**
    • ●
    • Calgary
    • ●
    • Canberra
    • ●
    • Cape Town
    • ●
    • Casablanca
    • ●
    • Chicago
    • ●
    • Dallas
    • ●
    • Denver
    • ●
    • Dubai
    • ●
    • Durban
    • ●
    • Frankfurt
    • ●
    • Hamburg
    • ●
    • Harare**
    • ●
    • Hong Kong
    • ●
    • Houston
    • ●
    • Istanbul
    • ●
    • Jakarta*
    • ●
    • Johannesburg
    • ●
    • Kampala**
    • ●
    • London
    • ●
    • Los Angeles
    • ●
    • Luxembourg
    • ●
    • Melbourne
    • ●
    • Mexico City
    • ●
    • Milan
    • ●
    • Minneapolis
    • ●
    • Montréal
    • ●
    • Munich
    • ●
    • New York
    • ●
    • Nairobi**
    • ●
    • Ottawa
    • ●
    • Paris
    • ●
    • Perth
    • ●
    • Piraeus
    • ●
    • Québec
    • ●
    • Riyadh*
    • ●
    • San Antonio
    • ●
    • San Francisco
    • ●
    • São Paulo
    • ●
    • Shanghai
    • ●
    • Singapore
    • ●
    • St. Louis
    • ●
    • Sydney
    • ●
    • Tokyo
    • ●
    • Toronto
    • ●
    • Vancouver
    • ●
    • Warsaw
    • ●
    • Washington DC *associate office **alliance
    Policies and disclaimers
    • Legal notices and disclaimers
    • Impressum
    • Standard terms
    • Blog network terms and conditions
    • Cookies policy
    • Privacy notice
    • Website access conditions
    • Fraud alerts
    • Modern Slavery Statements
    • Health plan machine readable files
    • Anti-Facilitation of Tax Evasion Statement
    • Suppliers
    • History
    • Remote access
    • Sitemap
    • Do Not Sell or Share My Personal Information
    • Limit the Use of My Sensitive Personal Information
    Visit our global site, or select a location
    North America
    • Canada (English)
    • Canada (Français)
    • United States
    Latin America
    • Brazil
    • Mexico
    Europe
    • Belgium
    • Deutschland (Deutsch)
    • France
    • Germany (English)
    • Greece
    • Italy
    • Luxembourg
    • Poland
    • The Netherlands
    • Türkiye
    • United Kingdom
    Middle East
    Africa
    • Burundi
    • Kenya
    • Morocco
    • South Africa
    • Uganda
    • Zimbabwe
    Asia Pacific
    • Australia
    • China
    • Hong Kong SAR
    • Indonesia
    • Japan
    • Singapore
    • Thailand
    Regional practices
    • India
    • Israel
    • Korea
    • Marshall Islands
    • Nordic region
    • Pakistan
    • Vietnam